Dr. Andrew H. Murr, MD

Dr. Murr practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Murr's NPI, 1710946157, was assigned on March 23, 2006. Dr. Murr graduated from Drexel University College Of Medicine in 1987. Dr. Murr holds California license G77382.

Dr. Murr's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Murr's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Murr to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murr practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Murr's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Murr is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Murr's licenses on file in 3 states: California, Massachusetts and Missouri.

Dmand AI lists chronic nasal allergies, chronic sinusitis, endoscopic sinus surgery and tinnitus among the conditions Dr. Murr treats.

CMS data shows 137 Medicare services from Dr. Murr across 5 procedure codes in 2024, for 62 Medicare patients. Medicare paid $6,857 for them. Every service was in an office.

CMS counts 62 Medicare patients who saw Dr. Murr in 2024. The largest group is 65 to 74, with 35 patients. 68% of them have high cholesterol, and 50% have high blood pressure. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Murr's median patient age at 71, with 53% women.

In 2024, Dr. Murr wrote 148 Medicare Part D claims for 41 patients. 93% of them were for generic drugs. CMS names the drug for 73 of them, across 4 drugs with 11 or more claims each, at $3,961 in total drug cost. In 2023, CMS named 36 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Murr for performance year 2024, reported as part of a group. Dr. Murr accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 43 papers to Dr. Murr, published from 2011 to 2025. 2011 was the busiest year, with 2. The most frequent topics are Sinusitis, Rhinitis and Tomography, X-Ray Computed. Dr. Murr has published most often in Laryngoscope. Dr. Murr's most frequent co-authors are Andrew N. Goldberg, MD, Steven Daniel Pletcher, MD and Kelvin Chee-Ming Lee, MD.

Dmand AI links Dr. Murr to 1 clinical trial. Conditions studied include Allergic Fungal Sinusitis and Nasal Polyps.

CMS Open Payments shows 51 general payments to Dr. Murr from 9 drug and device companies from 2016 to 2025. Accredited education speaker fees make up the largest share, 50% of the total. Synthes GmbH paid the most, $51,664.

Dmand AI lists 3 awards for Dr. Murr.

Dr. Murr graduated from Drexel University College Of Medicine in 1987. Dr. Murr is a member of NHS and ACS.

Dr. Murr is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.